Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $30.83.
OPCH has been the topic of several research analyst reports. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a research report on Thursday. JMP Securities lifted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and set a $27.00 price target on the stock. in a report on Monday. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th.
Get Our Latest Report on Option Care Health
Insiders Place Their Bets
Hedge Funds Weigh In On Option Care Health
Institutional investors have recently added to or reduced their stakes in the company. Norden Group LLC raised its stake in shares of Option Care Health by 42.3% in the first quarter. Norden Group LLC now owns 15,138 shares of the company’s stock worth $508,000 after acquiring an additional 4,501 shares during the last quarter. Diversify Advisory Services LLC bought a new stake in shares of Option Care Health during the first quarter worth $307,000. FORA Capital LLC raised its holdings in Option Care Health by 109.7% during the 1st quarter. FORA Capital LLC now owns 23,011 shares of the company’s stock worth $772,000 after purchasing an additional 12,037 shares during the last quarter. GSA Capital Partners LLP acquired a new position in Option Care Health during the 1st quarter valued at about $464,000. Finally, Texas Permanent School Fund Corp lifted its holdings in Option Care Health by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 155,023 shares of the company’s stock valued at $5,199,000 after buying an additional 2,008 shares during the period. 98.05% of the stock is owned by institutional investors.
Option Care Health Stock Performance
OPCH stock traded down $1.31 during trading on Monday, reaching $22.80. 260,433 shares of the company’s stock were exchanged, compared to its average volume of 1,467,324. Option Care Health has a 1-year low of $22.54 and a 1-year high of $34.63. The firm has a market cap of $3.88 billion, a PE ratio of 19.16, a P/E/G ratio of 1.74 and a beta of 1.32. The company’s fifty day moving average price is $30.49 and its 200-day moving average price is $29.91. The company has a quick ratio of 1.36, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- Overbought Stocks Explained: Should You Trade Them?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Use the MarketBeat Dividend Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- The How and Why of Investing in Gold Stocks
- 3 Stocks That Are Potential Takeover Targets in 2025
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.